Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Uncategorized

The Effectiveness of Kava and Saint John’s Wort for the Treatment of Anxiety and Depression

by Eric W. Dolan
January 14, 2010
in Uncategorized
Share on TwitterShare on Facebook

Dr. Sarris and Dr. Kavanagh conducted a systematic review of published research on the use of kava and Saint John’s Wort, which was published in The Journal of Alternative and Complementary Medicine in 2009. The study investigated the efficacy, pharmacology, and safety of kava and Saint John’s Wort as treatments for mood and anxiety disorders.

Kava

Kava (Piper methysticum) is a small leafy shrub that grows in warm, moist climates. “Kava” can also refer to the brew made from the roots of the kava plant.

The plant has traditionally been cultivated for medicinal purposes in the South Pacific because of its sedative effects. Recently, it has become available as an alternative medical treatment for anxiety in the form of kava root extracts, although the leaves are sometimes also used.

After reviewing the evidence from a number of published studies of kava, the authors of this study concluded that kava was an effective treatment for generalized anxiety disorder, but failed to find any studies that supported its effectiveness in alleviating the symptoms of obsessive-compulsive disorder, post-traumatic stress disorder, or specific phobias. Nor did the authors find any published study that supported the use of kava for depressive disorders.

Compared to other pharmaceutical substances, there is relatively little information about the pharmacokinetic effects of kava. The current evidence suggests that kava produces its anti-anxiety effects by interacting with GABA receptors in the hippocampus and amygdala, areas of the brain associated with emotion.

Kava has been banned in Canada, the United Kingdom, and the European Union because of fears that it causes liver damage. As the authors explain, “At least 93 cases of hepatotoxicity [liver damage] have been documented wherein kava may be implicated. Most cases were poorly reported and many involved the concurrent ingestion of pharmaceuticals and alcohol, excessive daily dosage or long-term administration.” Furthermore, the authors suggest that kava should be removed from over-the-counter use so that kava extracts can be standardized and monitored by health professionals.

Because of these concerns, kava should not be used alongside alcohol or by those with liver diseases.

Google News Preferences Add PsyPost to your preferred sources

Saint John’s Wort

Saint John’s Wort (Hypericum perforatum) is a small plant that has been used by both the ancient Greeks and Native Americans for a variety of medical purposes. Currently, extracts of Saint John’s Wort are used as an alternative treatment for depression.

According to Dr. Sarris and Dr. Kavanagh, Saint John’s Wort is “used extensively in Europe as an anti-depressant agent. In Germany [Saint John’s Wort] is one of the most prescribed antidepressant agents, with more than 100 million daily doses.”

The effectiveness of Saint John’s Wort is hotly debated. In their review, Dr. Sarris and Dr. Kavanagh found that in some cases Saint John’s Wort was more effective than synthetic antidepressants, but others believe that this is not the case. One study, the “Hypericum Depression Trial Study Group” published in 2002, found that the use of Saint John’s Wort was not more effective than placebo, but as Dr. Sarris and Dr. Kavanagh note, “What is commonly omitted in discussion of this trial is that it also found that sertaline [brand name Zoloft and Lustral] also had effects comparable to those of placebo.”

Dr. Sarris and Dr. Kavanagh concluded that Saint John’s Wort is an effective treatment of depression, but found little support that it is an effective treatment for other depressive disorders, such as Seasonal Affective Disorder (SAD) or Dysthymic disorder.

Like kava, little is known about the pharmacological effects of Saint John’s Wort. There are a variety of psychoactive substances in Saint John’s Wort (hyperforin, hypericin, etc) that appear to influence the re-uptake of the neurotransmitters serotonin, dopamine and norepinephrine similar to the way synthetic antidepressants such as Paxil and Zoloft work.

Due to the similarity between the effects of Saint John’s Wort and other antidepressants, the combination of Saint John’s Wort with antidepressants can cause dangerous side-effects, such as serotonin syndrome.

Reference:

Sarris, J. & Kavanagh, D.J. (2009). Kava and saint john’s wort: Current evidence for use in mood and anxiety disorders. The Journal of Alternative and Complementary Medicine, Vol 15, No 8: 827-836.

Previous Post

Hatha Yoga and the Treatment of Hyperkyphosis

Next Post

Facebook Profiles Can Be Used to Assess Levels of Narcissism

RELATED

Scientists link common “forever chemical” to male-specific developmental abnormalities
Uncategorized

Brain volume in bipolar disorder increases during depression and shrinks during remission

March 24, 2026
People with the least political knowledge tend to be the most overconfident in their grasp of facts
Uncategorized

People with the least political knowledge tend to be the most overconfident in their grasp of facts

March 7, 2026
Psychedelics may enhance emotional closeness and relationship satisfaction when used therapeutically
Uncategorized

Psychedelics may enhance emotional closeness and relationship satisfaction when used therapeutically

November 30, 2025
Evolutionary Psychology

The link between our obsession with Facebook and our shrinking brain

March 6, 2016
Uncategorized

UCLA first to map autism-risk genes by function

November 21, 2013
Uncategorized

Are probiotics a promising treatment strategy for depression?

November 16, 2013
Uncategorized

Slacktivism: ‘Liking’ on Facebook may mean less giving

November 9, 2013
Uncategorized

Educational video games can boost motivation to learn

November 7, 2013

STAY CONNECTED

RSS Psychology of Selling

  • When a goal-driven boss ignores relationships, manipulative employees may fight back
  • When salespeople fail to hit their targets, inner drive matters more than bonus checks
  • The “dark” personality traits that predict sales success — and when they backfire
  • What communication skills do B2B salespeople actually need in a digital-first era?
  • A founder’s smile may be worth millions in startup funding, research suggests

LATEST

A diet based on ultra-processed foods impairs metabolic and reproductive health, study finds

Psychologists identify nine core habits associated with healthy non-monogamous partnerships

Childhood trauma linked to elevated risk of simultaneous physical and mental illness in old age

Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder

How a twin study untangled the surprising roots of authoritarian political beliefs

Lifting weights can slow down biological brain aging in older adults

Women use a higher-pitched voice when speaking to unfamiliar dogs

Researchers break down the digital habits of science influencers

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc